Active Ingredient History
Ginsenosides or panaxosides are a class of natural product steroid glycosides and triterpene saponins. Compounds in this family are found almost exclusively in the plant genus Panax (ginseng), which has a long history of use in traditional medicine that has led to the study of pharmacological effects of ginseng compounds. As a class, ginsenosides exhibit a large variety of subtle and difficult-to-characterize biological effects when studied in isolation. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Altitude Sickness (Phase 3)
Alzheimer Disease (Phase 1/Phase 2)
Angina Pectoris (Phase 3)
Atherosclerosis (Phase 4)
Blood Pressure (Phase 2)
Bone Diseases, Metabolic (Phase 2/Phase 3)
Brain Waves (Phase 4)
Breast Neoplasms (Phase 2)
Cancer Survivors (Early Phase 1)
Cognition (Early Phase 1)
Colonic Neoplasms (Early Phase 1)
Colorectal Neoplasms (Phase 2)
Community-Acquired Infections (Phase 3)
COVID-19 (Phase 2/Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 2/Phase 3)
Endothelium (Phase 2)
Fatigue (Phase 4)
Fatigue Syndrome, Chronic (Phase 3)
Fibromyalgia (Early Phase 1)
Healthy Volunteers (Phase 4)
Hematoma (Phase 4)
Herbal Medicine (Phase 2/Phase 3)
HIV Infections (Phase 2)
Hyperglycemia (Phase 3)
Hyperlipidemias (Phase 2)
Hypersensitivity (Phase 4)
Hypertension (Phase 3)
Hypotension (Phase 2/Phase 3)
Immune System Diseases (Phase 4)
Infertility, Male (Phase 4)
Insulin Resistance (Phase 1/Phase 2)
Ischemic Stroke (Phase 4)
Leukemia (Phase 3)
Lymphoma (Phase 3)
Lymphoproliferative Disorders (Phase 3)
Malabsorption Syndromes (Phase 1)
Memory Disorders (Phase 3)
Metabolic Syndrome (Phase 1)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Neoplasms (Phase 3)
Obesity (Phase 2/Phase 3)
Palliative Care (Phase 2)
Palliative Medicine (Phase 2)
Precancerous Conditions (Phase 3)
Prehypertension (Phase 3)
Psychological Distress (Phase 3)
Psychotic Disorders (Phase 1/Phase 2)
Respiratory Tract Infections (Phase 3)
Schizophrenia (Phase 1/Phase 2)
Sports Medicine (Early Phase 1)
Sprains and Strains (Phase 1)
Stress, Psychological (Phase 1/Phase 2)
Tardive Dyskinesia (Phase 1/Phase 2)
Xerostomia (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
